Guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE); 2012 CRE toolkit
Corporate Authors:National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Division of Healthcare Quality Promotion.
Drug Resistance, Bacterial
Prevention & Control
Public Health Surveillance
Anti-Bacterial Agents/Therapeutic Use
Cross Infection/Prevention & Control/United States
Enterobacteriaceae Infections/Drug Therapy
Enterobacteriaceae Infections/Prevention & Control
Public Health Surveillance/United States
Description:This document contains two parts. Part 1 contains recommendations for healthcare facilities and is intended to expand upon the March 2009 "Guidance for Control of Carbapenem- Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute-Care Facilities.: Part 2 reviews the role of public health authorities in the control of carbapenem-resistant Enterobacteriaceae. Unless otherwise specified, healthcare facilities refer to all acute care hospitals and any long-term care facility that cares for patients who remain overnight and regularly require medical or nursing care (e.g., maintenance of indwelling devices, intravenous injections, wound care, etc.). This would include all long-term acute care hospitals and skilled nursing homes (including certain rehabilitation facilities), but would generally exclude assisted living facilities and nursing homes that do not provide more than basic medical care. In addition, this toolkit is not intended for use in ambulatory care facilities.
Supporting Files:No Additional Files
You May Also Like: